Q&A

Ginkgo is not a smart pill

Author and Disclosure Information

Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288:835–40.


 

ABSTRACT

BACKGROUND: Extracts of ginkgo have shown some promise in enhancing memory in demented elderly individuals.1 These authors set out to test the veracity of one manufacturer’s claim that ginkgo biloba “enhances mental focus and improves memory and concentration” in nondemented older adults.

POPULATION STUDIED: The authors solicited community-dwelling, functionally independent individuals older than 60 years who volunteered to participate in a study to improve memory. They excluded individuals with recent strokes, head injuries, or other “life-threatening illnesses,” mental illness or retardation, and persons who lacked someone to provide an evaluation of their memory and concentration. Participants were excluded if they scored less than 27 out of a possible 30 points on the Mini-Mental Status Examination at baseline. Highly educated or intelligent participants with mild dementia may have been included.

STUDY DESIGN AND VALIDITY: In this randomized controlled trial, participants received 40 mg of ginkgo biloba 3 times daily (the dose recommended by the manufacturer) or identical-appearing placebo for 6 weeks. This duration is 2 weeks longer than the manufacturer’s indicated onset of action. The number of subjects (230) was sufficient to detect a large effect. The researchers involved in dispensing study drugs and evaluating outcomes were effectively blinded, as were patients. Allocation to the control treatment groups may not have been concealed from the enrolling investigators. All persons screened for participation were accounted for, and the few dropouts were evenly balanced between the treatment and placebo groups. Analysis was by intention to treat.

OUTCOMES MEASURED: The authors measured performance on a wide variety of age-normed tests of memory, intelligence, and word-finding, such as the Wechsler Adult Intelligence Scale, well chosen to allow measurements to increase dramatically from baseline (ie, avoiding the ceiling effect that would be present if only tests for dementia were used). No quality of life measures were included. Companions were asked whether the subjects’ memory improved.

RESULTS: No statistically significant differences were noted between placebo and control groups on any of the scales measured. No significant changes from baseline to posttreatment and no adverse effects were found in either of the groups.

RECOMMENDATIONS FOR CLINICAL PRACTICE

Ginkgo, in standard doses for 6 weeks, was ineffective in improving memory, intelligence, and concentration in older patients without dementia. Because of the lack of regulation among herbal supplements, ginkgo products by other manufacturers might be effective. Nevertheless, if you do not currently recommend ginkgo supplements to older patients who are worried about memory loss, do not start now.

Recommended Reading

Can high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of macular degeneration?
MDedge Family Medicine
Improving influenza vaccination rates in the elderly
MDedge Family Medicine
The Role of Gynecologists in Providing Primary Care to Elderly Women
MDedge Family Medicine
Does a hip protector reduce the risk of hip fracture in frail elderly patients?
MDedge Family Medicine
Clinical Findings Associated with Radiographic Pneumonia in Nursing Home Residents
MDedge Family Medicine
Screening Mammography in Women Aged 70 to 79 Years
MDedge Family Medicine
Effects [FET1] of Influenza Vaccination of Health Care Workers on Mortality of Elderly People in Long-Term Care: A Randomized Controlled Trial
MDedge Family Medicine
Is losartan superior to captopril in reducing all-cause mortality in elderly patients with symptomatic heart failure?
MDedge Family Medicine
Is exposure to HMG-CoA reductase inhibitors (statins), fibrates, or other lipid-lowering drugs associated with reduced risk of bone fracture in older patients?
MDedge Family Medicine
Should we treat elevated cholesterol in elderly patients?
MDedge Family Medicine